Holger Wesche, Chief Scientific Officer at Harpoon Therapeutics, Inc. (HARP), sold 10,000 shares at $16.20 ($162K) on 2020-07-01, disclosed to the SEC on 2020-07-02.
Open-market sale of $162k HARP by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| HARP | SELL | 2021-01-06 | $314K | — | Filing → |
| HARP | SELL | 2020-10-05 | $163K | — | Filing → |
| HARP | SELL | 2020-05-13 | $20K | — | Filing → |